Want to join the conversation?
$TMO 2Q15 Q&A: Ross of Evercore ISI seeks answer on strong 4Q, weaker 1Q, recovery 2Q? We're in line with expectations. We had less days in Q1 vs. prior year. Some customers flush some money at the end of last year that bought some products & that led to a little bit of a softer start, but saw improvements happening & delivered a strong Q2.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.